Literature DB >> 22083307

Time-dependent changes in lipid metabolism in mice with methionine choline deficiency-induced fatty liver disease.

Han-Sol Park1, Byeong Hwan Jeon, Sung Hoon Woo, Jaechan Leem, Jung Eun Jang, Min Sock Cho, In-Sun Park, Ki-Up Lee, Eun Hee Koh.   

Abstract

Methionine and choline-deficient diet (MCD)-induced fatty liver is one of the best-studied animal models of fatty liver disease. The present study was performed to clarify the relative contributions of individual lipid metabolic pathways to the pathogenesis of MCD-induced fatty liver. Hepatic lipogenesis mediated by the sterol regulatory element-binding protein (SREBP-1c) was increased at 1 week, but not at 6 weeks, of MCD feeding. On the other hand, (14)C-palmitate oxidation did not change at 1 week, but significantly decreased at 6 weeks. This decrease was associated with increased expression of fatty acid translocase, a key enzyme involved in fatty acid uptake. Expression of endoplasmic reticulum stress markers was increased in mice given MCD for both 1 and 6 weeks. These findings suggest the presence of time-dependent differences in lipid metabolism in MCD-induced fatty liver disease: SREBP-1c-mediated lipogenesis is important in the early stages of fatty liver disease, whereas increased fatty acid uptake and decreased fatty acid oxidation become more important in the later stages.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083307      PMCID: PMC3887687          DOI: 10.1007/s10059-011-0184-6

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  24 in total

Review 1.  Orchestrating the unfolded protein response in health and disease.

Authors:  Randal J Kaufman
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 2.  Endogenous liver carcinogenesis in the rat.

Authors:  D Nakae
Journal:  Pathol Int       Date:  1999-12       Impact factor: 2.534

3.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

Review 4.  Animal models of steatosis.

Authors:  A Koteish; A M Diehl
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

Review 5.  Unfolding new mechanisms of alcoholic liver disease in the endoplasmic reticulum.

Authors:  Neil Kaplowitz; Cheng Ji
Journal:  J Gastroenterol Hepatol       Date:  2006-10       Impact factor: 4.029

6.  Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle.

Authors:  Jong-Yeon Kim; Timothy R Koves; Geng-Sheng Yu; Tod Gulick; Ronald N Cortright; G Lynis Dohm; Deborah M Muoio
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-05       Impact factor: 4.310

7.  Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins.

Authors:  Daisuke Yabe; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

Review 8.  Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury.

Authors:  Cheng Ji
Journal:  J Gastroenterol Hepatol       Date:  2008-03       Impact factor: 4.029

9.  CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.

Authors:  Nobuyuki Tamaki; Etsuro Hatano; Kojiro Taura; Masaharu Tada; Yuzo Kodama; Takashi Nitta; Keiko Iwaisako; Satoru Seo; Akio Nakajima; Iwao Ikai; Shinji Uemoto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-03       Impact factor: 4.052

Review 10.  Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.

Authors:  Catherine Postic; Jean Girard
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

View more
  8 in total

1.  Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH.

Authors:  Stephan Laggai; Yvette Simon; Theo Ranssweiler; Alexandra K Kiemer; Sonja M Kessler
Journal:  World J Hepatol       Date:  2013-10-27

2.  Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of nonalcoholic fatty liver disease.

Authors:  Weilin Liu; Dicky Struik; Vera J M Nies; Angelika Jurdzinski; Liesbeth Harkema; Alain de Bruin; Henkjan J Verkade; Michael Downes; Ronald M Evans; Tim van Zutphen; Johan W Jonker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

3.  A compromised liver alters polychlorinated biphenyl-mediated toxicity.

Authors:  Banrida Wahlang; Jordan T Perkins; Michael C Petriello; Jessie B Hoffman; Arnold J Stromberg; Bernhard Hennig
Journal:  Toxicology       Date:  2017-02-02       Impact factor: 4.221

4.  Si-Wu-Tang Alleviates Nonalcoholic Fatty Liver Disease via Blocking TLR4-JNK and Caspase-8-GSDMD Signaling Pathways.

Authors:  Yaxing Zhang; Ge Zhou; Zifeng Chen; Weibing Guan; Jiongshan Zhang; Mingmin Bi; Fenglin Wang; Xinchao You; Yangjing Liao; Shuhui Zheng; Kangquan Xu; Hongzhi Yang
Journal:  Evid Based Complement Alternat Med       Date:  2020-08-11       Impact factor: 2.629

5.  Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.

Authors:  Daniel A Giles; Maria E Moreno-Fernandez; Traci E Stankiewicz; Monica Cappelletti; Stacey S Huppert; Yoichiro Iwakura; Chen Dong; Shiva K Shanmukhappa; Senad Divanovic
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

6.  Loss of Hepatocyte-Specific PPARγ Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet.

Authors:  Jose Cordoba-Chacon
Journal:  PPAR Res       Date:  2020-05-01       Impact factor: 4.964

Review 7.  Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review).

Authors:  Mingmei Shao; Zixiang Ye; Yanhong Qin; Tao Wu
Journal:  Exp Ther Med       Date:  2020-08-28       Impact factor: 2.447

8.  Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation.

Authors:  David Fernández-Ramos; Fernando Lopitz-Otsoa; Laura Delacruz-Villar; Jon Bilbao; Martina Pagano; Laura Mosca; Maider Bizkarguenaga; Marina Serrano-Macia; Mikel Azkargorta; Marta Iruarrizaga-Lejarreta; Jesús Sot; Darya Tsvirkun; Sebastiaan Martijn van Liempd; Felix M Goni; Cristina Alonso; María Luz Martínez-Chantar; Felix Elortza; Liat Hayardeny; Shelly C Lu; José M Mato
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.